Related Experiment Video
Updated: May 18, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Assessing overall evidence from noninferiority trials with shared historical data
Guoxing Soon1, Zhiwei Zhang, Yi Tsong
1Division of Biometrics IV, Office of Biostatistics/CDER/FDA, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
Statistics in Medicine
|September 19, 2012
Summary
Regulatory requirements for drug approval mandate independent evidence from multiple studies. This study proposes a statistical framework to ensure independence in noninferiority trials, addressing concerns about current practices and enhancing drug development compliance.
Area of Science:
- Biostatistics
- Regulatory Science
- Clinical Trials
Background:
- The United States Code of Federal Regulations (CFR) requires 'substantial evidence' from 'adequate and well-controlled investigations' for drug approval.
- Current Food and Drug Administration (FDA) guidance interprets this as needing at least two independent studies, emphasizing independent substantiation of results.
- Concerns exist that noninferiority trials using shared historical data may lack true independence, potentially not meeting CFR requirements.
Purpose of the Study:
- To propose a statistical interpretation of the CFR requirement for noninferiority trials, focusing on trial-level and overall type I error rates.
- To examine whether existing analytical methods (fixed margin, synthesis) meet this proposed requirement in typical regulatory settings.
- To propose adjustments to existing methods when the criteria are not met, ensuring compliance and maintaining trial power.
Main Methods:
- Development of a statistical definition for the CFR requirement in noninferiority trials based on type I error rates.
- Analysis of four common regulatory scenarios using fixed margin and synthesis methods.
- Evaluation of existing methods against the proposed statistical criteria.
Main Results:
- The proposed statistical interpretation operationalizes the CFR requirement for noninferiority trials.
- Existing methods may not always fulfill the independence criteria in specific regulatory settings.
- Adjustments to analytical methods are proposed for non-compliant situations.
Conclusions:
- The study provides a framework for ensuring statistical independence in noninferiority trials, aligning with regulatory expectations.
- Findings offer guidance for designing and analyzing trials that are both compliant with CFR requirements and statistically powerful.
- The proposed methods can aid in robust drug approval processes by ensuring the integrity of evidence from multiple studies.
Related Concept Videos
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...